Dennis Kim

Dr. Dennis Kim is a physician biotechnology executive with specialty training in endocrinology/metabolism spanning approximately 20 years of drug/product development and corporate strategy experience in the biotech and medical technology industries. Dr. Kim joined Emerald Health Sciences in March of 2019 as the company’s Chief Medical Officer and has taken a leadership role in clinical development and brings business development experience across Emerald’s portfolio of companies. Prior to this, he was Chief Medical Officer at Zafgen for 7.5 years where he oversaw all aspects of clinical and medical affairs in the field of diabetes, obesity, and rare metabolic/genetic disorders. Prior to joining Zafgen, Dr. Kim held multiple senior-level positions at Orexigen Therapeutics (Sr. VP of Medical and Clinical Affairs), EnteroMedics (Chief Medical Officer), and Amylin Pharmaceuticals (Exec Director of Corporate Strategy). He holds an MD from the University of Health Sciences, The Chicago Medical School, an MBA from UCSD Rady School of Management, and a B.S. in biology from the University of California at Los Angeles. His endocrinology/metabolism specialty fellow training was completed at UCSD School of Medicine.